Breaking News, Collaborations & Alliances

Charles River, Nanoscope Therapeutics Enter Gene Therapy Manufacturing Pact

Collaboration is focused on restoring vision for people suffering from retinal degenerative diseases with no known cure.

Author Image

By: Charlie Sternberg

Associate Editor

Charles River Laboratories International Inc. and Nanoscope Therapeutics Inc., a clinical-stage biotechnology company, have announced a comprehensive manufacturing collaboration utilizing Charles River’s extensive contract development and manufacturing (CDMO) services in both plasmid DNA and viral vectors.   “We are excited to continue to support Nanoscope Therapeutics’ efforts in the production of gene therapies that are focused on restoring vision for people suffering from retinal degenerati...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters